122 as forming the aromatic cage, which is used by chromodomains to bind H3K9Me2 and 123 H3K9Me3 [15] . The presence of key basic residues, including 19 K and 4 R, is found in nuclear 124 proteins, for which they form part of nuclear localization signals, as well as sites for acetylation, 125 ubiquitination, and methylation; likely events involved in signaling within the cell nucleus.
126 Phosphorylatable residues include 6 T, 2 S, and 2 Y. This data is in agreement with previous 127 observations by our laboratory and others, which show that these residues are amenable to 128 extensive modifications in HP1 proteins, working as a subcode in regulating the function of reader 129 proteins that operate to fine-tune the histone code [16, 17] . The absence of the a CSD indicates that 130 the protein is not able to form the expected CSD-to-CSD interactions that support homo-and 131 hetero-dimerization of conventional HP1 proteins. Lastly, the protein has 13 E, which are known 132 to be characteristic of CD-containing proteins likely for reinforcing their binding to histone tails 133 that are in essence highly basic in nature [18] . Therefore, the new alternatively spliced mRNA, first 134 identified from pancreatic cancer RNA-Seq data [12] , as well as its predicted protein product would 135 expand the number of HP1 isoforms in human tissues. 
(A)
Physical map of a new HP1 isoform generated by alternative splicing. The 139 conventional HP1 is 183 residues and contains a chromodomain (CD) and a 140 chromoshadow domain (CSD). A shorter isoform lacks the CSD and is 101 residues. (B) 141 Protein sequences for HP1 generated by alternative splicing. Sequences with highlighted 142 CD (red) and CSD (blue), the sHP1 sequence generated by alternative splicing is 143 represented in gray. (C) The HP1 genomic structure (top) with dark blue boxes 144 representing constitutive exons. The lower panel illustrates mRNA splicing for the 145 canonical and sHP1 isoforms. CD is represented in red boxes, CSD is represented in 146 blue boxes and sHP1 sequence generated by alternative splicing is represented in gray 147 boxes. 148 149 150 Subsequently, we investigated the tissue distribution of sHP1γ mRNA. For this purpose, we first 151 used an isoform-specific qPCR method, designed to specifically detect the two different splice 152 junctions between exon 3 and 4 that are unique to the long and short HP1γ isoforms. Using this 153 method, we compared the expression levels of the novel sHP1γ encoding mRNA with that of the 154 conventional HP1γ isoform (Fig 2A) , in a normal human tissue mRNA panel. The results of this 155 experiment demonstrated that both types of mRNAs are expressed in the same pattern in most 156 human tissues. We found high levels of expression in the gastrointestinal and reproductive tracts, 157 namely pancreas, intestine, placenta, spleen and testis, and low signals present in urinary organs, 158 such as bladder and kidney, as well as in striated and cardiac muscle. The same isoform comparison 159 was made among 8 commonly-used pancreatic cancer cell lines (Fig 2B) , in which we detect 160 comparable levels to those found in the normal organ. Combined, these results demonstrate that 161 the CBX3 locus is spliced to give rise to a small isoform, sHP1γ, in various tissues. 
168
169 sHP1 transcript expression in healthy adult human tissues was obtained by processing data 170 derived from the Genotype-Tissue Expression project (GTEx) [19] . We analyzed 53 tissues 171 subdivided in 6 major groups (Reproductive, Other, Neurologic, Muscular, Blood, and GI). We 172 found that sHP1 is present in all tissues (Fig 3A) at a lower level yet in a fairly consistent ratio to 173 the conventional HP1 isoform (S1 Fig) . Long tails on these distributions indicate that there is a 174 small number of normal human samples that have significant up-regulation of sHP1γ, with the 175 heatmap further emphasizing these differences (Fig 3B) . We also investigated sHP1 expression 176 in malignant tumors using data from the Cancer Genome Atlas (TCGA) (Figs 3C and 3D) with a 177 particular focus on defining the ratio of short to long isoform for each cancer type ( S2 Fig) . We 178 noted interesting variability in the ratio of short to long HP1 among tumors, with the highest 179 levels of sHP1γ being found in esophageal cancer (ESCA), ovarian cancer (OV) and stomach 180 adenocarcinoma (STAD). Compared to non-tumor tissues, tumor groups are more uniform with a 181 much higher fraction of tumor samples from GI tissues and the blood expressing a higher level of 182 sHP1γ. Thus, these comparisons show that the two isoforms are expressed at a consistent ratio in 183 normal human tissues, but this ratio becomes more variable in different cancer types. 225 we detected a strong signal for sHP1 in the cell nucleus (Fig 4B) , where other members of this 226 family of chromatin proteins work. We also detected weak presence of sHP1γ in the cytoplasm, 227 which may reflect the ability of these proteins to bind to -importin, as demonstrated by our group, 228 to transport HP1 proteins from the cytoplasm to the nucleus [8] . This experimental evidence is 229 congruent with SLiM analyses, as performed by the ELM software [22] , which identifies a 230 monopartite NLS present in the non-conserved region of sHP1γ (a.a. 57-64). Interestingly, in 231 contrast, the long canonical isoform bears a bipartite form of this motif that conforms to the KRKS-232 (X 9 )-KSKKKR consensus sequence. In spite of many years of investigations in the field of protein 233 localization, no significant qualitative or quantitative differences have been reported between these 234 two types of domains. Thus, functionally, they are both considered to be highly effective nuclear 235 targeting sequences, which is congruent with our results that both isoforms primarily localize to 236 the cell nucleus. In summary, the combined data from western blot and immunofluorescence 237 analyses complement our findings with RNA-Seq and isoform-specific qPCR to reveal for the first 238 time that the CBX3/HP1γ gene, which is regulated by alternative splicing, is translated to a shorter 239 HP1γ protein in human cells where it primarily localizes to the cell nucleus. Thus, we subsequently 240 studied the molecular properties of this novel HP1γ isoform, using sequence-based bioinformatics 241 approaches, as well as homology-based molecular modeling and dynamic simulations. 246 Order-to-disorder predictions indicated that both the N (1-Met to 30 -Phe) and C-terminal (97-Leu 247 to 101-Glu) regions of sHP1γ are intrinsically disordered regions (IDR), while the residues located 248 between them (31-Val to 96-Val) exhibit the opposite characteristics (Fig 5A) . Interestingly, the 249 final 45 amino acids at the C-terminus have no sequence similarities with other members of the 250 CBX family, to which this protein belongs. However, fold recognition analyses using the JPRED4 251 algorithm [23] revealed that the sequence scores well for the CD protein fold and for protein folds 283 between the turns and the helix defines a cavity or channel to horizontally accommodate the 284 histone tail peptide (Fig 6C) . A surface rendition of the sHP1γ-H3K9Me3 peptide complex, 285 displayed in Fig 6D, better shows how the histone tail peptide becomes buried into this cavity.
286 Figs 6E and 7A depict the contact between the H3K9Me3 mark and the aromatic cage formed by 287 F30, W51, and F54. Molecular dynamics (MD) simulations (5 ns) revealed a time-dependent 288 interaction between these aromatic residues and H3K9Me3 (Fig 7B) . In addition, we noted during 289 dynamic simulations that other residues, such as E26 and E28, are also critical for maintaining 290 these intermolecular interactions (Fig 7B) . Root mean square fluctuations (RMSF) values obtained 291 during MD simulations, as a measure of regional displacements, demonstrated that the while the 292 IDR and helix region of these protein are quite dynamic, binding to the histone tail restricts the 293 fluctuations of the CD (Fig 7C) . To guide protein purification experiments that consider 294 hydrodynamic radius, such as in gel filtration or ultracentrifugation, we modeled the surface 295 properties of sHP1γ as a globular protein in solution (Fig 7D) . We measured the molecular 296 properties of this protein when given a water-accessible surface, according to the method of Neil 297 R. Voss and Mark Gerstein [31] . These properties, which are listed in Table 3 , when compared to 298 the conventional HP1 as modeled by Velez, et al.[8] indicate that sHP1γ is significantly smaller 299 (sHP1γ volume 16443Å 3 as compared to HP1γ, 32517Å 3 ) and more spherical (sHP1γ 0.53Ψ as 300 compared to HP1γ 0.39Ψ). Therefore, although shorter in length and different in sequence, sHP1γ 301 appears to conserve some of the most salient structural features of the CBX family of proteins.
302 These findings should be taken into consideration when studying the repertoire of HP1 proteins 303 expressed in humans. 354 that the CBX3 locus gives rise to mRNA that encodes a novel spliced form of the CBX3 locus, 355 which we termed small HP1, sHP1. We present both bioinformatics-based and experimentally-356 derived evidence demonstrating that the mRNA for this novel isoform is widely expressed in both 357 normal and many different cancer types of human tissues. A peptide-specific antibody against 358 sHP1 confirmed that this protein is indeed translated. Furthermore, immunofluorescence-based 359 microscopy corroborated bioinformatics-based predictions for this protein with localization to the 360 cell nucleus. Thus, combined, these experiments report, for the first time, the existence of a bona 361 fide CSD-less HP1 isoform, which is not specific to PDAC, but rather widely expressed in a 362 variety of human tissues.
